RSSSubstance Use Disorders

Letter to the Editor: The Ever-changing Landscape of the Opioid Crisis: Fentanyl and its Analogs

Letter to the Editor: The Ever-changing Landscape of the Opioid Crisis: Fentanyl and its Analogs

| November 1, 2018

By Adegboyega Oyemade, MD, FAPA Funding/financial disclosures. The author has no conflict of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2018;15(11–12):11–12 Dear Editor: Fentanyl was created in 1960 as an intravenous surgical anesthetic (Sublimaze®, Janssen Pharmaceuticals Inc.), which is 50 to 100 […]

Continue Reading

Letter to the editor: Marijuana on the brain— a concern

Letter to the editor: Marijuana on the brain— a concern

| February 1, 2018 | 0 Comments

Continue Reading

Methadone Treatment of Opiate Addiction: A Systematic Review of Comparative Studies

Methadone Treatment of Opiate Addiction: A Systematic Review of Comparative Studies

| July 1, 2017 | 0 Comments

by Shahid Ali, MD; Barira Tahir, MD; Shagufta Jabeen, MD; and Madeeha Malik Drs. Ali and Tahir are with the Smart Choice Treatment Center in Franklin, Tennessee. Ms. Malik is a Research Associate with the Smart Choice Treatment Center in Franklin, Tennessee. Dr. Jabeen is Site Director of the VA Residency Training Program in Nashville […]

Continue Reading

When the Opioid Medications Go Missing: Confidentiality and Safety in Adolescents

When the Opioid Medications Go Missing: Confidentiality and Safety in Adolescents

| June 1, 2017 | 0 Comments

by Muhammad Hassan Majeed, MD Dr. Majeed is an Attending Psychiatrist at Natchaug Hospital, Norwich, Connecticut. Innov Clin Neurosci. 2017;14(5–6):25–27 Funding: No funding was received for the preparation of this article. Financial Disclosures: The author has no conflicts of interest relevant to the content of this article. Keywords: Opioids, diversion, safety, confidentiality, adolescents Abstract: Patients receiving […]

Continue Reading

The Neuroscience Report—Vol. 40 (May 6, 2016): Anti-addiction Medications

The Neuroscience Report—Vol. 40 (May 6, 2016): Anti-addiction Medications

| May 6, 2016 | 0 Comments

The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information. This week’s […]

Continue Reading

Medical Marijuana for Epilepsy?

Medical Marijuana for Epilepsy?

| April 1, 2016 | 0 Comments

by Murali K. Kolikonda, MD; Kavitha Srinivasan, MD; Manasa Enja, MD; Vishwanath Sagi, MD; and Steven Lippmann, MD Drs. Kolikonda and Sagi are from the Department of Neurology, Dr. Srinivasan is from the Clinical Translational Research Support Unit, and Drs. Enja and Lippmann are from the Department of Psychiatry, University of Louisville School of Medicine, […]

Continue Reading